drugset / Trial / NCT05670353
Cannabidiol for the Treatment of Pelvic Pain in Endometriosis (DREAMLAND)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this work is to conduct a randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of cannabis extract in women with endometriosis who have already undergone hormonal contraceptive treatment and surgery without satisfactory response.
Timeline
- Start
- 2023-01-03
- Primary completion
- 2024-09-12
- Completion
- 2024-11-20
Outcome
Outcome not reported
Stopped: “The study was prematurely terminated due to the results of the interim analysis conducted, as outlined in the initial project plan.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CBD | Unknown | 150 mg | Oral |